Integer (NYSE:ITGR) Hits New 12-Month High – Should You Buy?

Integer Holdings Corporation (NYSE:ITGR) shares reached a new 52-week high during trading on Friday . The company traded as high as $112.01 and last traded at $121.2250, with a volume of 263588 shares trading hands. The stock had previously closed at $100.86.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ITGR shares. Zacks Research raised Integer from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. HC Wainwright reaffirmed a “buy” rating on shares of Integer in a research report on Friday, July 24th. Piper Sandler reiterated an “overweight” rating and set a $97.00 price objective (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Finally, KeyCorp reissued an “overweight” rating and issued a $104.00 target price on shares of Integer in a research note on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.00.

Integer Price Performance

The firm has a market capitalization of $4.11 billion, a PE ratio of 30.19, a PEG ratio of 2.89 and a beta of 0.64. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The firm has a 50-day simple moving average of $93.88 and a 200-day simple moving average of $88.95.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The business had revenue of $439.58 million for the quarter, compared to the consensus estimate of $426.48 million. During the same period in the previous year, the firm earned $1.31 EPS. The company’s revenue was up .5% on a year-over-year basis. As a group, equities analysts forecast that Integer Holdings Corporation will post 6.04 earnings per share for the current year.

Hedge Funds Weigh In On Integer

Hedge funds and other institutional investors have recently modified their holdings of the stock. Assenagon Asset Management S.A. bought a new stake in Integer in the 2nd quarter valued at $746,000. GAMMA Investing LLC lifted its stake in Integer by 91.1% in the 2nd quarter. GAMMA Investing LLC now owns 3,846 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 1,833 shares in the last quarter. Harbor Investment Advisory LLC bought a new position in shares of Integer during the 2nd quarter valued at about $42,000. Versant Capital Management Inc boosted its holdings in shares of Integer by 24.2% during the 2nd quarter. Versant Capital Management Inc now owns 3,114 shares of the medical equipment provider’s stock valued at $291,000 after purchasing an additional 606 shares during the last quarter. Finally, Defilade Capital Management L.P. purchased a new position in shares of Integer during the first quarter valued at about $18,746,000. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.